Live Breaking News & Updates on Bell Canada International

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer
Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has appointed veteran corporate finance and capital markets professional, Gordon Neal to the Board of Directors. Additionally, Dean Ditto has joined the Company as Chief Financial Officer. “MYCO continues to …
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has appointed veteran corporate finance and capital markets professional, Gordon Neal to the Board of Directors. Additionally, Dean Ditto has joined the Company as Chief Fi ....

United States , New Brunswick , British Columbia , Los Angeles , Nesbitt Burns , Josh Bartch , Charles Lee , Joshua Bartch , Gordon Neal , Anne Donohoe Nick Opich , Corp Communication , Bell Mobility , Bell Canada International , Mydecine Innovations Group Media Contacts , Vp Corporate Development , Mydecine Innovations Group , Pacific Metals Corp , Canadian Securities Exchange , Mydecine Innovations Group Inc , Indiana University , Dalhousie University , Silver Corp , Strategic Communications , Dalhousie University Senate , Kelley School Of Business , Health Canada ,